Ovarian cancer
Results
Phase 2
This trial looked at gemcitabine as well as paclitaxel and carboplatin for ovarian cancer and primary peritoneal cancer.
Recruitment start: 13 June 2005
Recruitment end: 14 June 2006
Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.
Professor Stanley Kaye
Eli Lilly and Company Limited
National Institute for Health Research Cancer Research Network (NCRN)
Scottish Gynaecological Cancer Trials Group
Last reviewed: 05 May 2011
CRUK internal database number: 667
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
